| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/16/2002 | WO2002006502A3 Adenovirus vectors comprising introns |
| 05/16/2002 | WO2002002640A3 Antibodies to human mcp-1 |
| 05/16/2002 | WO2002000708A3 Mutants of prostase |
| 05/16/2002 | WO2001098335A3 Transgenic algae for delivering antigens to an animal |
| 05/16/2002 | WO2001096587A3 Methods for administering recombinant adeno-associated virus virions to humans previously exposed to adeno-associated virus |
| 05/16/2002 | WO2001087270A3 Vaccine composition, method of preparing the same, and method of vaccinating vertebrates |
| 05/16/2002 | WO2001085789A3 Extracellular domain of ryk protein for regulating angiogenesis |
| 05/16/2002 | WO2001080879A3 Colorectal cancer vaccines and diagnosis |
| 05/16/2002 | WO2001075109A3 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability |
| 05/16/2002 | WO2001070953A3 Identification of modulators of the inteferon gamma signaling pathway and their use in restenosis treatment |
| 05/16/2002 | WO2001070663A3 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| 05/16/2002 | WO2001068144A3 Biodegradable immunomodulatory formulations and methods for use thereof |
| 05/16/2002 | WO2001068143A3 Immunomodulatory formulations and methods for use thereof |
| 05/16/2002 | WO2001058526A3 Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof |
| 05/16/2002 | WO2001048163A3 Dioxygenases catalyzing the asymetric cleavage of beta-carotene |
| 05/16/2002 | WO2001047959A3 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 05/16/2002 | WO2001041798A9 Induction of immunoglobulin class switching by inactivated viral vaccine |
| 05/16/2002 | WO2001040521A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 05/16/2002 | WO2001039802A9 Chimeric flavivirus vaccines |
| 05/16/2002 | WO2001034636A9 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/16/2002 | WO2001027294A9 Virus coat protein/receptor chimeras and methods of use |
| 05/16/2002 | WO2001025408A9 Isolated dishevelled associated kinases, polynucleotides encoding the kinases, and methods of use thereof |
| 05/16/2002 | US20020058804 Includes an active therapeutic agent joined to a blocking moiety sensitive to the catalytic action of molecules having retro- aldol and retro-Michael catalytic activity; antitumor; anticarcinogenic agents |
| 05/16/2002 | US20020058799 Novel pth |
| 05/16/2002 | US20020058797 Nef-attachable protein, DNA encoding the protein and a monoclonal antibody against said protein |
| 05/16/2002 | US20020058796 defl |
| 05/16/2002 | US20020058789 Polypeptide for use as tool in the diagnosis of microorganism infections |
| 05/16/2002 | US20020058636 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 05/16/2002 | US20020058615 Endothelial specific targeting |
| 05/16/2002 | US20020058614 Especially administered by direct injection into the afflicted cartilagenous region or joint. |
| 05/16/2002 | US20020058609 Compositions and methods using complexes of calreticulin and antigenic molecules |
| 05/16/2002 | US20020058322 DNA molecules encoding fibrinolytically active polypeptide |
| 05/16/2002 | US20020058312 Plasmid for use in the the treatment and prevention of viral disease |
| 05/16/2002 | US20020058293 Nucleotide sequences coding microorganismal protein; for use in the prevention of preferential microorganismal infection |
| 05/16/2002 | US20020058292 Ovarian tumor antigen and methods of use therefor |
| 05/16/2002 | US20020058288 Compound for use in the detection and prevention of parasitic infection of humans |
| 05/16/2002 | US20020058284 Methods and compositions for treating macrophage-mediated diseases |
| 05/16/2002 | US20020058267 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's disease |
| 05/16/2002 | US20020058069 Use of microparticles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration |
| 05/16/2002 | US20020058067 Solid drug delivery system |
| 05/16/2002 | US20020058047 Vaccines |
| 05/16/2002 | US20020058046 Vaccines against neosporosis useful in the prevention of clinical disease and abortion in mammals. |
| 05/16/2002 | US20020058044 LVPs associated with human immunoglobulins having a density of less than 1.063 g/ml. |
| 05/16/2002 | US20020058043 Attenuated human rotavirus vaccine |
| 05/16/2002 | US20020058042 Non-IgA fc binding forms of the Group B streptococcal beta antigens |
| 05/16/2002 | US20020058041 Kidney-specific tumor vaccine directed against kidney tumor antigen G-250 |
| 05/16/2002 | US20020058040 Injectable vaccine composition comprising an immunogenic conjugate in a water in oil emulsion; enhanced immunogenicity after storage at about -18 degrees C. |
| 05/16/2002 | US20020058038 Specific octapeptides, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds and immune effector cells raised in response to presentation of these epitopes. |
| 05/16/2002 | US20020058036 Novel fibroblast growth factor and nucleic acids encoding same |
| 05/16/2002 | US20020058034 Treating or ameliorating an autoimmune condition, an allergic reaction or asthma |
| 05/16/2002 | US20020058033 Human anti-epidermal growth factor receptor single-chain antibodies |
| 05/16/2002 | US20020058029 Anti-CD40L, anti-B7.1 (CD80), anti-B7.2(CD86), CD40 antibody or anti-CD4 antibody; both may be administered separately or in combination, and in any order. |
| 05/16/2002 | US20020058022 Novel compounds |
| 05/16/2002 | US20020058021 Plasmid containing a nucleotide sequence encoding an immunogen of a pathogen to allow in vivo expression of this sequence, and as a cationic lipid, 2,3-di-c12-18-alkoxy-N-(amino- or hydroxyalkyl)-N,N-dimethylpropylammonium salt |
| 05/16/2002 | CA2429000A1 Adjuvant combination formulations |
| 05/16/2002 | CA2428453A1 C. elegans genes involved in viability and/or reproduction and uses thereof |
| 05/16/2002 | CA2428176A1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 05/16/2002 | CA2428117A1 Immunogenic compositions comprising liver stage malarial antigens |
| 05/16/2002 | CA2428110A1 Methods and compositions for the control of coccidiosis |
| 05/16/2002 | CA2428103A1 Vaccines with enhanced immune response and methods for their preparation |
| 05/16/2002 | CA2427622A1 Methods for detecting the efficacy of anticancer treatments |
| 05/16/2002 | CA2426037A1 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
| 05/16/2002 | CA2425829A1 Proteases |
| 05/16/2002 | CA2399276A1 Novel therapeutic compositions for treating infection by lawsonia spp |
| 05/15/2002 | EP1205547A2 DNA mutagenesis by random fragmentation and reassembly |
| 05/15/2002 | EP1205489A1 Polypeptide and nucleic acids encoding the same |
| 05/15/2002 | EP1204764A2 Methods of screening for angiogenesis modulators |
| 05/15/2002 | EP1204754A2 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 05/15/2002 | EP1204753A2 Invasive bacteria based viral vaccines |
| 05/15/2002 | EP1204752A2 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof |
| 05/15/2002 | EP1204751A2 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 05/15/2002 | EP1204750A1 Basb126 polypeptide and polynucleotide from moraxella catarhalis |
| 05/15/2002 | EP1204749A2 Moraxella catarrhalis antigens basb122 and basb124 |
| 05/15/2002 | EP1204748A2 New g-protein coupled receptor and dna sequences thereof |
| 05/15/2002 | EP1204747A1 G protein-coupled receptor expressed in brain |
| 05/15/2002 | EP1204744A1 Isolated peptide of the horny layer and use thereof |
| 05/15/2002 | EP1204683A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 05/15/2002 | EP1204682A2 Compositions and methods for the treatment of tumors |
| 05/15/2002 | EP1204678A1 Moraxella cattarrhalis basb114 antigens and uses thereof |
| 05/15/2002 | EP1204674A2 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders |
| 05/15/2002 | EP1204430A2 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes |
| 05/15/2002 | EP1204425A2 Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein |
| 05/15/2002 | EP1204424A1 Recombinant rsv virus expression systems and vaccines |
| 05/15/2002 | EP1204423A1 Therapeutic antibody against muc-1 antigen and methods for their use |
| 05/15/2002 | EP1204422A2 Stress-proteins from extra-cellular pathogens as vaccines against infectious agents |
| 05/15/2002 | EP1204421A2 Stress protein-peptide complexes as vaccines against intra-cellular pathogens |
| 05/15/2002 | EP1204420A2 Trehalose producing prokaryotic cells as vaccines |
| 05/15/2002 | EP1204419A1 Inhibitors of the lectin complement pathway (lcp) and their use |
| 05/15/2002 | EP1204409A1 Microparticles for pulmonary administration |
| 05/15/2002 | EP0750509B1 USE OF IL-12 AND IL-12 ANTAGONISTS for the manufacture of a pharmaceutical composition for THE TREATMENT OF AUTOIMMUNE DISEASES |
| 05/15/2002 | EP0688329B1 Novel phospholipid-saccharide conjugates |
| 05/15/2002 | CN1349410A Use of heparin-binding antagonists in the inhibition of bradykinin release |
| 05/15/2002 | CN1349408A Pegylated interferon alfa-CCR5 antagonist combination HIV therapy |
| 05/15/2002 | CN1348991A Rotavirus causing adult's diarrhea and its culture process |
| 05/14/2002 | US6388132 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/14/2002 | US6388056 Inhibition of transglutaminase-mediated microbial interaction with a mammalian host |
| 05/14/2002 | US6387888 Prostate cancer |
| 05/14/2002 | US6387701 Method of identifying tumor antigens that elicit a T-cell response |
| 05/14/2002 | US6387698 Polyclonal antiserum produced by immunzing animal with tumor rejection antigen precursor |
| 05/14/2002 | US6387682 Amino acid sequence of polypeptide with cysteine protease activity; treatment of bone disorders such as osteoporosis; anticarcinogenic agents; antitumor agents; antimetastasis agents |